Richard Horton on the Oxford vaccine phase 3 trial - Listen - The - Chartable

The Lancet in conversation with

Richard Horton on the Oxford vaccine phase 3 trial

Listen now

Description

Editor-in-chief of The Lancet, Richard Horton, discusses the results of the Oxford vaccine's phase 3 trial.

More Episodes

Prasad Kulkarni on a vaccine against typhoid and paratyphoid

Published 05/02/24

Patricia Campbell and Frans Rutten on heart failure with preserved ejection fraction

Published 03/28/24

Lene Seidler on umbilical cord management at preterm birth

Published 12/21/23